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Lesson
Intractable masturbation has been reported after epilepsy
surgery and can be difficult to control, we present a case
treated with cyproterone acetate and haloperidol to
achieve an endocrine based resolution of symptoms.
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Introduction
We present the case of a boy with intractable mastur-
bation after epilepsy surgery effectively controlled by
cyproterone acetate and haloperidol.
Case description
A 16-year-old boy presented with a history of autism
spectrum disorder with learning difficulties, and
attention deficit hyperkinetic disorder.
Having been born at term following an uneventful
pregnancy, he developed complex partial epilepsy aged
16 weeks old occurring up to 70 times daily. He was
initially optimised on oral anti-epileptic medication.
However, his seizures became uncontrollable and at
age 12 he underwent a successful right temporal lobec-
tomy and a radical amygdalo-hippocampectomy,
which significantly reduced his seizure frequency.
However, he developed sexualised behaviour, charac-
terised by incessant masturbation in any environment
such that hewas unable to interact with anyone outside
his immediate family. Cognitive behavioural support
proved unsuccessful. Aged 16, he was referred to the
endocrinology and neuropsychology clinics.
Management
Physical examination showed incomplete pubertal
development with Tanner stage 3 genitalia. There
was no evidence that his sexual behaviours were
electro-neurophysiological in origin.
After neurodevelopmental and neuropsychiatric
examination, it was felt that his behaviour might
in part be androgen driven. His family consented to
a trial of cyproterone acetate 50mg once daily.
Within two weeks, the masturbation completely
ceased and he was able to resume his social
relationships.
His bone age at the start of treatment was reported
as normal. The family were aware of the potential for
the anti-androgenic effects on his bones but felt that
given the clear benefits, cyproterone should be
continued. The drug maintained excellent control
for about three months and then the effect began to
fade. In addition to the resurgence of the masturba-
tion, he had developed recurrent symptoms of affect-
ive mood disorder. Low dose of haloperidol (3mg
daily) was started for its prolactin mediated endocrine
anti-libidinal side-effects and the dose of his cyproter-
one was increased to 50mg in the morning and 25mg
in the evening.
The combination of cyproterone and haloperidol
successfully abolished the incessant masturbation in
inappropriate settings. He now engages in socially
appropriate masturbation in his room at a much
reduced rate. However, his bone mineral density
scan four years after starting his cyproterone
showed T scores for his lumbar spine of 3.2 and
of his left hip 2.9. Wrist X-rays assessing his bone
age when repeated 5 years after starting his cyproter-
one showed epiphyseal fusion. Similarly, when
plotted aged 14 years and 6 months, his height was
just above the 0.4th centile and his height was on the
9th centile using standard UK charts for boys. Aged
17 years and 9 months, his height and weight were
both on the 9th centile. When last measured, aged 22
years and 10 months, his testosterone remained low at
1.1 nmol/l (8.6–29.0).
! 2019 The Author(s)
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://
www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided
the original work is attributed as specified on the SAGE and Open Access pages (https://uk.sagepub.com/en-us/nam/open-access-at-sage).




We have described the successful treatment of a
12-year-old boy who developed hypersexualized con-
duct in the form of excessive masturbation following
a right temporal lobe resection and right amygdalo-
hippocampectomy for cortical dysplasia using a com-
bination of cyproterone acetate and haloperidol.
It has been suggested that pharmacotherapy is
unsuccessful in controlling seizures in 30–40% of
patients with epilepsy.1 For those deemed suitable,
surgery may be considered. However, hypersexuality
has previously been reported as a recognised compli-
cation of epilepsy surgery.2–4 Such behaviours may be
all consuming, leading to charges and convictions of
sexual misconduct.3
Temporal lobe resection is a common treatment for
drug resistant epilepsy.1 However, it can be complicated
by postoperative changes in sexual behaviour.
Historically, findings of sexual dysfunction after bilat-
eral anterior temporal lobectomy in male rhesus
monkeys was first reported by Klu¨ver and Bucy.3,5
Others have reported that the Klu¨ver–Bucy syndrome
is characterized by ‘excessive orality and hyperphagia,
distractibility (especially for visual stimuli), hypersexu-
ality and change in sexual preference, visual agnosia
and loss of aggressive and fearful responses’.5,6
This syndrome was first described in humans in
1955 by Terzian and Ore, following a temporal lob-
ectomy.7 However, these reports are rare, with
Ozmen et al. describing a 14-year-old girl who mas-
turbated incessantly in inappropriate places after a
left amygdalo-hippocampectomy.4
In a study of personality changes following tem-
poral lobectomy for epilepsy, more than half (15 out
of 27) experienced increased sexual drive and
potency.8 These postoperative changes in sexual
behaviour or function have also led to abolition of
pre-existing paraphilia as well as a decline in libido or
sexual activity, with apparent restoration of ‘normal’
sexual function.2 As with our patient, the onset
of these changes in sexual behaviour occurred char-
acteristically in the first three postoperative months.2
Three potential mechanisms for the appearance of
this hypersexual behaviour following temporal lobec-
tomy have been proposed. The first is based on the
notion that prior to surgery the uncontrolled epilepti-
form neuronal activity within the brain inhibits
normal limbic function leading to preoperative hypo-
sexuality. Following surgery, this removal of inhibi-
tory signalling leads to a rebound in hypersexual
behaviour.2,9 This would be consistent with the data
from Braun et al., who describe the hemispheric con-
tribution to libido.10 They suggest the intact right
hemisphere inhibits libido and the left enhances it.
They suggest that the right temporal lobe resection
or lesions that interfered with the normal functioning
of the right temporal lobe would lead to hypersexu-
ality and vice versa.10
The second potential mechanism is that the lobe
that is not operated on may have a degree of unrec-
ognised pathological change which only comes to
light with the removal of the more damaged lobe.2
The final proposed mechanism is that the physical
expression of the hypersexual behaviour may be a
normal part of the postoperative psychosocial adjust-
ment.9 Given the disparate nature of the proposed
mechanisms for developing hypersexual symptoms
postoperatively, different treatment strategies have
been tried. Ozmen et al. successfully used 20mg cita-
lopram in their case.4 Others have used a combination
of quetiapine and sertraline with excellent results.3 As
far as we are aware, the current case is the first report
of the successful use of cyproterone acetate.
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